Gries Financial »

Jasper Therapeutics shares owned by Gries Financial

Quarter-by-quarter ownership of Jasper Therapeutics shares owned by Gries Financial from 13F filings

Historical chart of Gries Financial investment in Jasper Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Jasper Therapeutics held by Gries Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jasper Therapeutics by Gries Financial

Quarter filed Position value Share count Share price at filing
2023-09-30 $17k 24k 0.70
2023-06-30 $33k 24k 1.37

More positions owned by Gries Financial

Ishares Tr Core S&p500 Etf (IVV)
RBB Us Treas 3 Mnth (TBIL)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Cintas Corporation (CTAS)
Blackstone Secd Lending Common Stock (BXSL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ishares Tr TRS FLT RT BD (TFLO)
Ishares Tr U.s. Tech Etf (IYW)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Msci Usa Min Vol (USMV)

View all positions for Gries Financial

Top funds holding Jasper Therapeutics

Soleus Capital Management
Carlyle
Qiming U.S. Ventures Management
Octagon Capital Advisors
Vanguard Group
Opaleye Management
Kingdon Capital Management
Bank of America Corporation
Nantahala Capital Management
Landscape Capital Management
Sphera Funds Management
Mariner Wealth Advisors
Bank Of Montreal
Monaco Asset Management SAM
Citadel Advisors

View all funds holding Jasper Therapeutics